Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,902 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05398367Recruiting
Supplement study to help low milk supply during breastfeeding
This study tests whether a supplement (either an active “galactagogue” or a placebo) can increase milk supply in people who feel they have low breast milk. You would have several check-ins and milk/milk-expression measurements to see if your milk volume changes.
Rock Hill, South CarolinaAges 18–40 - NCT04328337RecruitingPhase 1/Phase 2
Study tests how rising fatty acids affect brain fuel use
This early-phase study will raise fatty acid levels temporarily and see how the brain uses glucose (sugar) and processes energy. It may help researchers understand how metabolism in the body can change brain function.
Chapel Hill, North CarolinaAges 18–45 - NCT06487832Recruiting
Effect of diabetes drug on brain response to insulin
This study tests whether a GLP-1 receptor agonist (a type of diabetes medicine) changes how the brain responds to insulin in people with different body sizes. It may help understand if this drug can improve brain function related to insulin.
TübingenAges 18–70 - NCT07258849RecruitingPhase 1
Study of LY4213663 in healthy people and rheumatoid arthritis
This study tests a new medicine called LY4213663 in healthy volunteers and people with rheumatoid arthritis. It aims to see if the medicine is safe and how the body handles it.
Anniston, AlabamaAges 18–75 - NCT07250802RecruitingPhase 3
Long-term study of zasocitinib for children with plaque psoriasis
This trial tests a daily pill (zasocitinib) for children and teens with moderate to severe plaque psoriasis that hasn't been controlled by other treatments. It aims to see if the pill can safely improve skin symptoms over a long period.
Chula Vista, CaliforniaAges 4–17 - NCT07253285RecruitingPhase 3
Study on cagrilintide and CagriSema for kids with excess weight
This trial tests two new medicines (cagrilintide and CagriSema) to see if they help children and teens lose weight. It's for young people who have tried lifestyle changes without enough success.
Escondido, CaliforniaAges 8–18 - NCT07251023RecruitingPhase 3
Testing a new drug for Alzheimer's dementia
This study tests whether a new drug called Latrepirdine (DMB-I) is safe and effective for people with mild to moderate Alzheimer's dementia. It may help slow cognitive decline when added to current treatment or used alone.
Kazan'Ages 60–90 - NCT07255209RecruitingPhase 3
A study of IBI362 for Chinese teens with obesity or overweight
This trial tests a new medicine, IBI362, to help Chinese adolescents lose weight. It may be an option if you are 12 to 17 years old and have obesity or overweight with a related health condition.
Hangzhou, ZhejiangAges 12–18 - NCT07254481RecruitingPhase 1
Safety study of VB19055 in healthy volunteers
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
HangzhouAges 18–50 - NCT07250750RecruitingPhase 1/Phase 2
IM-101 for generalized and ocular myasthenia gravis
This study tests a new medicine called IM-101 in people with myasthenia gravis (MG), a muscle weakness condition. It aims to see if it can safely help manage symptoms.
Altamonte Springs, FloridaAges 18–74 - NCT07251595RecruitingPhase 2
Testing a pill and gel for vitiligo
This trial tests two forms of a drug (SHR0302) for non-segmental vitiligo. One is a pill, the other a gel. The goal is to see if they can repigment the skin with fewer side effects.
Jinan, ShandongAges 18–75 - NCT07251309RecruitingPhase 3
Study of WS016 for treating high potassium levels
This trial tests a new drug called WS016 to lower high potassium levels in adults. High potassium can be dangerous for your heart, and this study aims to find out if WS016 is safe and effective.
Bengbu, AnhuiAges 18 years+ - NCT07252492Recruiting
Testing a new hearing device for people with hearing loss
This study tests a new hearing device called 'Audiocap' to see if it helps people with mild to moderate hearing loss hear better. It may be an option if you are getting your first hearing aid.
Lyon, FranceAges 18 years+ - NCT07251998RecruitingPhase 2
A study of ICP-332 for moderate to severe plaque psoriasis
This trial tests an oral medication called ICP-332 versus a placebo (a pill with no active drug) for people with moderate to severe plaque psoriasis. The goal is to see if ICP-332 can improve skin symptoms and be safe.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06686693RecruitingPhase 4
IV iron and exercise at high altitude
This study tests whether giving iron through a vein helps you perform better at high altitude. It may help you if you are a healthy adult who exercises regularly.
Natick, MassachusettsAges 18–40 - NCT06843174RecruitingPhase 4
Methadone for pain during and after spine surgery
This trial tests if giving a single dose of methadone right before and during spine surgery can help manage pain better. If it works, you might need fewer other pain medicines after surgery.
Toronto, OntarioAges 18–65 - NCT07251296Recruiting
Exercise and supplement study for menopausal women
This study tests whether a program of functional exercise combined with a nutritional supplement can help improve symptoms like hot flashes, sleep, and mood in women going through menopause. It may be a good fit if you are between 45 and 65, have moderate menopause symptoms, are not very active, and are not using hormone therapy or certain medications.
Valencia, ValenciaAges 45–65 - NCT07255248RecruitingPhase 4
Knee fat pad pain study for young female athletes
This study tests a treatment for knee fat pad pain in teenage girls who play organized sports. It aims to see if a specific injection helps after physical therapy hasn't worked.
Norwood, MassachusettsAges 12–18 - NCT07258160RecruitingPhase 2
Cordycepin for low CD8+ cells in solid tumor patients
This trial tests a supplement derived from cordyceps mushrooms to see if it can raise low CD8+ immune cell levels in people who have had solid tumors. It may help strengthen your immune system after previous cancer treatments.
Suzhou, JiangsuAges 18 years+ - NCT07259252Recruiting
Flu vaccine study for heart attack or unstable angina patients
This study tests whether getting a flu vaccine helps people who recently had a heart attack or unstable angina (acute coronary syndrome). It looks at whether vaccination can reduce future heart problems.
Wuhan, HubeiAges 18–80 - NCT07252778RecruitingPhase 2/Phase 3
Probiotics for endurance athletes
This trial tests if taking a probiotic supplement for a short time can help athletes who do endurance sports like rowing. If you are a healthy athlete on a national team, this study might help you understand how probiotics affect performance.
Poznan, WielkopolskaAges 16–50 - NCT07257198RecruitingPhase 3
Aspirin-free care with ticagrelor after a heart attack treated without stents or bypass
This trial tests whether taking ticagrelor (a blood thinner) alone, without aspirin, is safe and effective for people who have had a heart attack and are being treated with medication only (no stents or bypass surgery). It could mean fewer pills and possibly reduce bleeding risks.
Montreal, QuebecAges 18 years+ - NCT07254429RecruitingPhase 2
The Copenhagen Menopause Study for hot flash relief
This study tests a new treatment for women going through menopause who have frequent hot flashes. It aims to find a safe and effective way to reduce moderate to severe hot flashes.
HerlevAges 40–65 - NCT07254403Recruiting
Beef vs. plant protein for muscle health in older adults
This study compares how well beef protein and plant protein help build muscle in older adults who may be starting to feel weak or lose muscle. You'll eat test meals and have your muscle response measured using a safe, stable isotope technique.
College Station, TexasAges 65–95
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,902 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.